The Association of Private Hospitals of Malaysia (APHM) calls for a collaborative, evidence-based, and sustainable long-term solution to address the issue of health cost inflation in Malaysia.
Since December 2024, APHM has been in discussions with key government ministries, government agencies, policymakers and other key stakeholders in addressing this issue.
APHM’s commitment to achieving an evidence-based, and sustainable long-term solution has been ongoing. In 2024, APHM commissioned an independent study on medical cost inflation, the findings of which will be presented to the Ministry of Health (MOH) in early February 2025. This independent study aims to identify the factors contributing to medical cost inflation in Malaysia.
In addressing private hospital patient concerns on transparency, APHM has advised its member hospitals to implement Drug Price Transparency for Out-Patient Departments (OPD) by April 2025 in line with the Ministry of Health’s broader strategy to enhance cost containment within the health care sector.
Private hospitals in Malaysia are resolutely dedicated to work with the Ministry of Health to reduce the burden of patient care in Malaysia, as evidenced in private-public health care collaboration during the Covid-19 pandemic, and the outsourcing of selected treatments to private hospitals through ProtectHealth Corporation.
Through ongoing efforts to balance quality, transparency, and affordability, we can together meet the diverse needs of patients while reinforcing Malaysia’s position as a leading destination in health care excellence.
- This is the personal opinion of the writer or publication and does not necessarily represent the views of CodeBlue.
